Loading...
Zoledronic Acid for the Treatment and Prevention of Primary and Secondary Osteoporosis
There is increasing interest in therapies that can be administered less frequently and/or avoid gastrointestinal irritation. The efficacy of once-yearly zoledronic acid (5 mg) in the treatment and prevention of osteoporosis has been evaluated in different patient populations. In the 3-year HORIZON-P...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383464/ https://ncbi.nlm.nih.gov/pubmed/22870433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X09352920 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|